Assesses data on acecarbromal, carbromal, clomethiazole, chloralodol,
methylpentynol, triclofos, and secobarbital. For each, recommendations
concerning the need for, and level of, control are made following an assessment
of available data on the similarity to already known compounds and effects on
the central nervous system, dependence potential, likelihood of abuse, and
therapeutic usefulness. The book also contains detailed reports on five designer
drugs : three analogues of fentanyl, MPPP, and PEPAP. All five were recommended
for control in Schedules I and IV...